BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25372534)

  • 1. Multimodal imaging in a case of deferoxamine-induced maculopathy.
    Gelman R; Kiss S; Tsang SH
    Retin Cases Brief Rep; 2014; 8(4):306-9. PubMed ID: 25372534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodal imaging in deferoxamine retinopathy.
    Viola F; Barteselli G; DellʼArti L; Vezzola D; Mapelli C; Villani E; Ratiglia R
    Retina; 2014 Jul; 34(7):1428-38. PubMed ID: 24378427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deferoxamine-induced electronegative ERG responses.
    Jauregui R; Park KS; Bassuk AG; Mahajan VB; Tsang SH
    Doc Ophthalmol; 2018 Aug; 137(1):15-23. PubMed ID: 29770904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectral domain optical coherence tomography findings in early deferoxamine maculopathy: report of two cases.
    Van Bol L; Alami A; Benghiat FS; Rasquin F
    Retin Cases Brief Rep; 2014; 8(2):97-102. PubMed ID: 25372319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal fundus autofluorescence results of patients in long-term treatment with deferoxamine.
    Viola F; Barteselli G; Dell'arti L; Vezzola D; Villani E; Mapelli C; Zanaboni L; Cappellini MD; Ratiglia R
    Ophthalmology; 2012 Aug; 119(8):1693-700. PubMed ID: 22480740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case Report: Retinal Toxicity Secondary to Ritonavir.
    Louie AK; Jones HN
    Optom Vis Sci; 2019 May; 96(5):376-381. PubMed ID: 31046022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deferoxamine retinopathy: spectral domain-optical coherence tomography findings.
    Wu CH; Yang CP; Lai CC; Wu WC; Chen YH
    BMC Ophthalmol; 2014 Jul; 14():88. PubMed ID: 24989140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macular vitelliform lesion in desferrioxamine-related retinopathy.
    Genead MA; Fishman GA; Anastasakis A; Lindeman M
    Doc Ophthalmol; 2010 Oct; 121(2):161-6. PubMed ID: 20532952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deferoxamine-related ocular toxicity: incidence and outcome in a pediatric population.
    Baath JS; Lam WC; Kirby M; Chun A
    Retina; 2008 Jun; 28(6):894-9. PubMed ID: 18536609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudovitelliform maculopathy associated with deferoxamine toxicity: multimodal imaging and electrophysiology of a rare entity.
    Bui KM; Sadda SR; Salehi-Had H
    Digit J Ophthalmol; 2017; 23(1):11-15. PubMed ID: 28924413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilateral central serous retinopathy in a patient with paroxysmal nocturnal hemoglobinuria treated with deferoxamine.
    Vahdani K; Makrygiannis G; Kaneshyogan H; Sian IS; Giasin O
    Eur J Ophthalmol; 2016 Nov; 26(6):e152-e154. PubMed ID: 27445073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desferrioxamine related maculopathy: a case report.
    Arora A; Wren S; Gregory Evans K
    Am J Hematol; 2004 Aug; 76(4):386-8. PubMed ID: 15282675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid development of severe toxic retinopathy associated with continuous intravenous deferoxamine infusion.
    Lai TY; Lee GK; Chan WM; Lam DS
    Br J Ophthalmol; 2006 Feb; 90(2):243-4. PubMed ID: 16424543
    [No Abstract]   [Full Text] [Related]  

  • 14. Functional and Structural Abnormalities in Deferoxamine Retinopathy: A Review of the Literature.
    Di Nicola M; Barteselli G; Dell'Arti L; Ratiglia R; Viola F
    Biomed Res Int; 2015; 2015():249617. PubMed ID: 26167477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectral-domain optical coherence tomography and fundus autofluorescence findings in a case of laser pointer-induced maculopathy.
    Rusu I; Sherman J; Gallego-Pinazo R; Lam M; Freund KB
    Retin Cases Brief Rep; 2013; 7(4):371-5. PubMed ID: 25383813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodal imaging of torpedo maculopathy in a Chinese woman: a case report.
    Ding Y; Yao B; Ye H; Yu Y
    BMC Ophthalmol; 2019 Jul; 19(1):154. PubMed ID: 31324167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilateral vitelliform maculopathy and deferoxamine toxicity.
    Gonzales CR; Lin AP; Engstrom RE; Kreiger AE
    Retina; 2004 Jun; 24(3):464-7. PubMed ID: 15187676
    [No Abstract]   [Full Text] [Related]  

  • 18. Electrophysiological features and multimodal imaging in ritonavir-related maculopathy.
    Faure C; Paques M; Audo I
    Doc Ophthalmol; 2017 Dec; 135(3):241-248. PubMed ID: 28900746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimodal imaging of poppers maculopathy.
    Romano F; Arrigo A; Sperti A; Bandello F; Battaglia Parodi M
    Eur J Ophthalmol; 2021 Mar; 31(2):NP71-NP73. PubMed ID: 31746225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expanded clinical spectrum of deferoxamine retinopathy.
    Haimovici R; D'Amico DJ; Gragoudas ES; Sokol S;
    Ophthalmology; 2002 Jan; 109(1):164-71. PubMed ID: 11772599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.